Brief: Protagenic Therapeutics Inc - On Nov 19, Co Receives Nasdaq Delist Determination Letter
22/11/2024 21:21
Nov 22 (Reuters) - Protagenic Therapeutics Inc PTIX.O :
* PROTAGENIC THERAPEUTICS INC - ON NOV 19, CO RECEIVES
NASDAQ
DELIST DETERMINATION LETTER
Source text: [https://tinyurl.com/w8538fz9]
Further company coverage: PTIX.O
Recent news on Protagenic Therapeutics
See all newsBrief: Protagenic Therapeutics Inc - Alexander Arrow, CFO, To Be Terminated Effective April 30, 2026 - SEC Filing
Brief: Protagenic Therapeutics Approves Restructuring Plan on August 8- SEC Filing
Brief: Protagenic Therapeutics Granted Japanese Patent JP 7714571B
Brief: Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2 - SEC Filing
Brief: Protagenic Therapeutics - May Offer And Sell, From Time To Time, Shares Of Common Stock Of Up To $1.2 Mln